- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (161)
- Timeline of Article Publication (5)
- Authors Evaluation (6)
- Article Quality Tracking (0)
- Reference Citation Analysis (2)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5021)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2024 (publication date) through Jun 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang T, Chao K, Zhu X, Wang XD, Chan S, Guan YP, Mao J, Li P, Guan SX, Xie W, Gao X, Huang M. Early proactive monitoring of DNA-thioguanine in patients with Crohn’s disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers. World J Gastroenterol 2024; 30(12): 1751-1763 [PMID: 38617736 DOI: 10.3748/wjg.v30.i12.1751] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i12/1751.htm |
| Number | Citing Articles |
| 1 |
Abhirup Chatterjee, Prateek Bhatia, Saroj K Sinha, Anupam K Singh, Harshal S Mandavdhare, Jimil Shah, Vaneet Jearth, Arpit Sasani, Aravind Sekar, Minu Singh, Usha Dutta, Vishal Sharma. Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study. Expert Review of Clinical Pharmacology 2025; 18(3): 175 doi: 10.1080/17512433.2025.2465425
|
| 2 |
Cai-Yun Long, Ying Huang. Proactive pharmacogenomics in azathioprine-treated pediatric inflammatory bowel disease at a Chinese tertiary hospital. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1558897
|
| 3 |
Giulia Zudeh, Martina Franzin, Marianna Lucafò, Matteo Bramuzzo, Debora Curci, Jun J. Yang, Maud Maillard, Giuliana Decorti, Gabriele Stocco. Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients. ACS Pharmacology & Translational Science 2025; doi: 10.1021/acsptsci.5c00135
|
| 4 |
Ahmed B. Bayoumy, A. R. Ansari, C. J. J. Mulder, K. Schmiegelow, Timothy Florin, N. K. H. De Boer. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical Pharmacokinetics 2024; 63(8): 1089 doi: 10.1007/s40262-024-01393-0
|
| 5 |
Ahmed Bayoumy Bayoumy, Ludovicus Jozef Johannes Derijks, Nanne Klaas Hendrik de Boer. DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2025; 31(2): 612 doi: 10.1093/ibd/izae234
|